Risk of endometriosis |
Observational; cross-sectional or cohort study |
Girls and women before menopause |
Habitual intake assessed by FFQ (nutrients, foods) |
Presence (cross-sectional) or new cases (cohort) of endometriosis based on complaints (questionnaires: EHP-30) and clinical confirmation by ultrasound, MRI or surgery |
Associations between severity of subjective and clinical endometriosis complaints and diet |
Cross-sectional study, observational or longitudinal study |
Women with clinically confirmed endometriosis |
Habitual intake of foods or nutrients by FFQ |
Subjective outcomes: pelvic pain, mood and quality of life |
|
|
|
Clinical outcomes: subfertility; presence of endometriosis lesions on ultrasound, MRI or surgery and cyst size |
Effect of diet on endometriosis-related complaints |
Intervention, one group design with measurements before and after start of diet |
Women with clinically confirmed endometriosis; subgroups based on type of endometriosis; use of oral contraceptives; past surgical treatment for endometriosis |
Whole diet: (e.g. Mediterranean, healthy eating); Elimination diet: (e.g. low FODMAP); specific foods: (e.g. fruits and vegetables) |
Subjective outcomes (e.g. pelvic pain, mood, quality of life) as assessed by questionnaires (EHP-30). |
|
|
|
Clinical outcomes (e.g. Inflammation markers, presence of endometriosis lesions on ultrasound, MRI or surgery; cyst size) |
Intervention, parallel groups including placebo |
Women with clinically confirmed endometriosis; subgroups based on type of endometriosis; use of oral contraceptives; past surgical treatment for endometriosis |
Specific nutrients: (e.g. vitamin D or omega-6 fatty acids) |
Subjective outcomes (e.g. pelvic pain, mood, quality of life) as assessed by questionnaires (EHP-30). |
|
|
|
Clinical outcomes (e.g. Inflammation markers, presence of endometriosis lesions on ultrasound, MRI or surgery, cyst size) |
Mechanistic studies |
Observational or intervention study |
Women with clinically confirmed endometriosis |
Any dietary intervention |
Immune cells in peripheral blood and/or menstrual effluent: cytokines, neutrophils, granulocytes (including mast cells and macrophages), chemokines and different subsets of T-cells |